Safety and Efficacy of Three Variants of Canaloplasty With Phacoemulsification to Treat Glaucoma and Cataract
NCT ID: NCT02908633
Last Updated: 2016-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2016-02-29
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Glaucoma and Cataract
NCT01726543
Comparison of Phaco-Trabeculectomy and MSICS-Trab in Cataract and Glaucoma Patients
NCT06739343
Anterior Lens Capsule as a Spacer in the Deep Sclerectomy _ Phacoemulsification
NCT05906212
Combined VCST With Phacoemulsification Versus Phacoemulsification in Primary Angle Closure Glaucoma
NCT06120621
Phaco-UCP Versus Phaco Alone for OAG and Cataract
NCT04430647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
canaloplasty ab externo and phacoemulsification
As soon as the two scleral flaps: deep and superficial -similar to deep sclerectomy are dissected, the phacoemulsification with PCIOL insertion is performed. After excision of the deep flap the descemets window and ostia of Schlemm canal are created, the microcatheter is placed in the canal and guided for 360 degrees within the canal. Surgeon observes the location of beacon tip through sclera and injects the Healon GV. Then a suture is tied to the distal tip and the microcatheter is withdrawn. As it appears at the other ostium of canal the microcatheter it separated from the suture.Then suture loop is tightened to tension the trabecular meshwork. The superficial flap is sutured watertight to prevent bleb formation
canaloplasty and phacoemulsification
canaloplasty ab interno and phacoemulsification
This variant of canaloplasty spares conjunctival surface. First phacoemulsification and PCIOL placement is performed. The Schlemm's canal is reached through goniotomy through anterior chamber. Similarly microcatheter is inserted and viscodilatator applicated. The key difference, is that no tensioning suture is left after the catheter is withdrawn. phacoemulsification is performed.
canaloplasty and phacoemulsification
minicanaloplasty and phacoemulsification
The dissected conjunctival flap is of minimal size. The scleral flaps are sized: superficial flap 3x1mm, and deep flap: 1x1 mm- with no removal of the deep flap. Afterwards phacoemulsification part is performed. The microcatheterization and viscodilatation are conducted as in the traditional procedure.The conjunctiva is closed with one suture or coagulation
canaloplasty and phacoemulsification
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
canaloplasty and phacoemulsification
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* glaucoma types: primary open angle glaucoma,
* eye with characteristic glaucoma changes (biomicroscopic,visual field)
* IOP over 21 mmHg after washout
* patients not tolerating antiglaucoma medications,
* patients with poor compliance
* progression in visual field
Exclusion Criteria
* previous cataract surgery
* BCVA under 0,004
* closed angle glaucoma secondary glaucoma (pseudoexfoliative, pigmentary)
* poorly controlled diabetes mellitus
* advanced AMD
* active inflammatory disease
* pregnancy
* mental disease or emotional instability general steroid therapy
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Military Institute od Medicine National Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marek Rekas
MD, PhD Professor of Ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Military Institute of Medicine
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Danielewska ME, Kicinska AK, Placek MM, Lewczuk K, Rekas M. Changes in spectral parameters of corneal pulse following canaloplasty. Graefes Arch Clin Exp Ophthalmol. 2019 Nov;257(11):2449-2459. doi: 10.1007/s00417-019-04433-9. Epub 2019 Aug 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
76/WIM/015
Identifier Type: OTHER
Identifier Source: secondary_id
76/WIM/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.